ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1622570
Orthogonal Design-Based Investigation of Dose, Time Point, and Treatment Course on the Toxicity-Efficacy Transition of Triptolide in Collagen-Induced Arthritis Mice
Provisionally accepted
- Nanjing University of Chinese Medicine, Nanjing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In recent years, the potential application of Tripterygium wilfordii Hook f. (WHTF) in the treatment of rheumatoid arthritis (RA) has garnered increasing attention in both academic research and clinical practice. However, the effective use of rheumatoid arthritis is limited in clinical practice by its severe toxic side effects. We conducted a comprehensive analysis of the effects of triptolide dose, treatment course, and time point on the clinical efficacy and safety of treating experimental arthritis. This work employed an orthogonal design grouping and three-factor, three-level dose, treatment course, and time point modeling of collagen-induced arthritis (CIA) in female C57BL/6 mice. Using smears from exfoliated mouse vaginal cells, the estrous cycle was observed. Mice blood was tested by the enzyme linked immunosorbent assay (ELISA) for ovarian hormones such as estradiol (E2) and follicle stimulating hormone (FSH), as well as inflammatory markers such as interleukin-6 (IL-6) and interleukin-17A (IL-17A). In CIA mice, triptolide changed serum E2 and FSH levels, the estrous cycle, arthritis scores, IL-6, and IL-17A levels. The inhibitory effect of triptolide on IL-17A was significantly influenced by the time point of administration. For triptolide therapy of CIA mice, a high benefit-low risk dosage schedule is 150 μg/kg/d -23:00-6 weeks. Therefore, in clinical applications, optimizing the TWHF dosing regimen (including dose, time point, and treatment course) may help to minimize ovarian toxicity while retaining therapeutic efficacy.
Keywords: Triptolide, collagen-induced arthritis, Rheumatoid arthritis, Orthogonal array design, reproductive toxicity
Received: 08 May 2025; Accepted: 25 Jul 2025.
Copyright: © 2025 Huang, Xu, Wu, Cheng, Sun and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zhe Feng, Nanjing University of Chinese Medicine, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.